A proposal floated Tuesday by outgoing President Joe Biden to require Medicare and Medicaid to offer coverage for prescriptions of popular but expensive injectable weight loss drugs had the tentative ...

The Biden Administration released plans for a new rule that would require Medicare and Medicaid to cover anti-obesity ...

Whether millions gain access to breakthrough anti-obesity treatments may depend on Kennedy, Mehmet Oz and other key players ...

Discover how Trump’s healthcare picks could reshape U.S. biopharma and drive major changes in the healthcare policy.

North Carolina stopped covering weight loss drugs such as Ozempic for state employees without diabetes. But it extended ...

This summary covers recent developments in the health sector, including studies on thyroid medications and asthma drugs, ...

Biden's new proposal would significantly expand access to anti-obesity drugs such as Ozempic and Wegovy. Without insurance coverage, the drugs can cost as much as $1,000 a month. Lawmakers previously ...

The Biden administration announced Tuesday it’s reinterpreting federal law to allow Medicare and Medicaid patients access to ...

A new HHS rule would require Medicare and Medicaid to cover drugs like Wegovy or Zepbound for a large segment of Americans.

Data gathered from the Central Disease Center and the American Diabetes highlights a health crisis in Arkansas.

Millions of Americans would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic covered by Medicare ...